Galmed Pharmaceuticals (GLMD) EPS (Basic) Growth (1y) (2014 - 2020)
Galmed Pharmaceuticals (GLMD) EPS (Basic) Growth (1y) (2014 - 2020) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EPS (Basic) Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
-51.11% |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
186.69% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
104.24% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
-52.19% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-79.34% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
-100.01% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
61.11% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Galmed Pharmaceuticals |
2.48 Mn |
-1.63 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2020 |
-12.34% |
| Dec 31, 2019 |
24.47% |
| Sep 30, 2019 |
246.33% |
| Mar 31, 2019 |
75.65% |
| Dec 31, 2018 |
84.57% |
| Sep 30, 2018 |
-43.04% |
| Mar 31, 2018 |
18.68% |
| Dec 31, 2017 |
14.80% |
| Sep 30, 2017 |
18.72% |
| Mar 31, 2017 |
10.39% |
| Dec 31, 2016 |
-2.98% |
| Sep 30, 2016 |
-14.37% |
| Jun 30, 2016 |
4.95% |
| Mar 31, 2016 |
1.38% |
| Dec 30, 2015 |
48.53% |
| Sep 30, 2015 |
-13.19% |
| Jun 30, 2015 |
26.88% |
| Mar 31, 2015 |
-89.51% |
| Jun 30, 2014 |
41.09% |
| Mar 31, 2014 |
2,080.05% |
